| Financial Year |
March 31 2023 |
| Monetary Funds |
4,263,567,913.80 |
| Held-for-trading Financial Assets |
4,421,889,444.76 |
| Notes Receivable |
467,351,728.57 |
| Accounts Receivable |
945,672,843.97 |
| Advances to Suppliers |
272,609,568.30 |
| Other Receivables |
188,985,528.96 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
-- |
| Inventories |
739,748,587.05 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
265,510.61 |
| Other Current Assets |
138,050,436.37 |
| Total Current Assets |
12,421,229,676.69 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
1,560,280.48 |
| Long-term Equity Investment |
4,085,584,727.13 |
| Investment Properties |
27,487,296.77 |
| Fixed Assetes |
11,640,632,890.42 |
| Under-construction Projects |
2,170,314,022.20 |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
709,639,381.97 |
| R&D expenses |
-- |
| Goodwill |
1,536,596,981.49 |
| Long-Term Deferred and Prepaid Expenses |
103,600,196.95 |
| Deferred Income Tax Assets |
157,495,539.55 |
| Other Non-Current Assets |
3,035,310,827.16 |
| Sub-Total of Non-Current Assets |
26,389,080,917.70 |
| Total Assets |
38,810,310,594.39 |
| Short-Term Loans |
746,451,598.69 |
| Trading Financial liabilities |
141,836,249.97 |
| Notes Payable |
806,811,909.80 |
| Accounts Payable |
2,450,391,652.37 |
| Accounts Received In Advance |
-- |
| Employee Compensation Payable |
113,507,042.97 |
| Taxes Payable |
206,571,772.85 |
| Interest Payable |
-- |
| Dividend Payable |
-- |
| Other payables |
1,930,260,748.92 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
1,462,939,968.83 |
| Other Current Liabilities |
106,381,590.93 |
| Sub-Total of Current Liabilities |
8,449,440,647.32 |
| Long-term Loans |
1,168,681,266.12 |
| Bonds Payable |
-- |
| Long-Term Accounts Payable |
-- |
| Special Payable |
-- |
| Estimatied Liabilities |
249,519.52 |
| Deferred Income Tax Liabilities |
334,262,814.86 |
| Other Non-Current Liabilities |
-- |
| Sub-Total of Non-Current Liabilities |
3,260,998,808.26 |
| Total Liabilities |
11,710,439,455.58 |
| Paid-In Capital(Or Share Stock) |
8,438,017,390.00 |
| Capital Surplus |
337,384,863.99 |
| Surplus Reserve |
1,682,241,342.47 |
| LESS:Treasury Stock |
-- |
| Undistributed Profits |
15,983,892,397.53 |
| Minority Stockholder's Interest |
610,154,196.56 |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
26,489,716,942.24 |
| Owner's Equity（Stockholder's Equity） |
27,099,871,138.80 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
38,810,310,594.39 |
